Expression and Purification of Functional Recombinant CUL2•RBX1 from E. Coli

Overview

Journal Sci Rep

Specialty Science

Date 2021 May 28

PMID 34045610

Citations 8

Authors

Stephanie Diaz

Lihong Li

Kankan Wang

Xing Liu

Affiliations

Soon will be listed here.

Abstract

Cullin-2 (CUL2) based cullin-RING ligases (CRL2s) comprise a family of ubiquitin E3 ligases that exist only in multi-cellular organisms and are crucial for cellular processes such as embryogenesis and viral pathogenesis. CUL2 is the scaffold protein that binds one of the interchangeable substrate receptor modules, which consists of adaptor proteins and the substrate receptor protein. The VHL protein is a substrate receptor known to target hypoxia-inducible factor α (HIF1α) for ubiquitination and degradation. Because of its critical role in the ubiquitination of important cellular factors such as HIF1α, CRL2s have been investigated for their biological functions and the development of novel therapeutics against diseases. Given the importance of CRL2s in biological and biomedical research, methods that efficiently produce functional CUL2 proteins will greatly facilitate studies on the mechanism and regulation of CRL2s. Here, we report two cost-effective systems for the expression and purification of recombinant human CUL2 from E. coli cells. The purified CUL2 proteins were ~ 95% pure, could bind their substrate receptor modules, and were enzymatically active in transferring ubiquitin or ubiquitin-like protein to the corresponding substrate in in vitro assays. The presented methodological advancements will help advance research in CRL2 function and regulation.

Citing Articles

Mechanism of degrader-targeted protein ubiquitinability.

Crowe C, Nakasone M, Chandler S, Craigon C, Sathe G, Tatham M Sci Adv. 2024; 10(41):eado6492.

PMID: 39392888 PMC: 11468923. DOI: 10.1126/sciadv.ado6492.

Mechanism of Ψ-Pro/C-degron recognition by the CRL2 ubiquitin ligase.

Chen X, Raiff A, Li S, Guo Q, Zhang J, Zhou H Nat Commun. 2024; 15(1):3558.

PMID: 38670995 PMC: 11053023. DOI: 10.1038/s41467-024-47890-5.

Cullin-RING ligases employ geometrically optimized catalytic partners for substrate targeting.

Li J, Purser N, Liwocha J, Scott D, Byers H, Steigenberger B Mol Cell. 2024; 84(7):1304-1320.e16.

PMID: 38382526 PMC: 10997478. DOI: 10.1016/j.molcel.2024.01.022.

Mechanism of millisecond Lys48-linked poly-ubiquitin chain formation by cullin-RING ligases.

Liwocha J, Li J, Purser N, Rattanasopa C, Maiwald S, Krist D Nat Struct Mol Biol. 2024; 31(2):378-389.

PMID: 38326650 PMC: 10873206. DOI: 10.1038/s41594-023-01206-1.

CAND1 inhibits Cullin-2-RING ubiquitin ligases for enhanced substrate specificity.

Wang K, Diaz S, Li L, Lohman J, Liu X Nat Struct Mol Biol. 2024; 31(2):323-335.

PMID: 38177676 PMC: 10923007. DOI: 10.1038/s41594-023-01167-5.

References

Nguyen H, Yang H, Fribourgh J, Wolfe L, Xiong Y . Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex. Structure. 2015; 23(3):441-449. PMC: 4351159. DOI: 10.1016/j.str.2014.12.014. View

Zhuang M, Calabrese M, Liu J, Waddell M, Nourse A, Hammel M . Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell. 2009; 36(1):39-50. PMC: 2847577. DOI: 10.1016/j.molcel.2009.09.022. View

Smith B, Wang S, Jaime-Figueroa S, Harbin A, Wang J, Hamman B . Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat Commun. 2019; 10(1):131. PMC: 6328587. DOI: 10.1038/s41467-018-08027-7. View

Cavadini S, Fischer E, Bunker R, Potenza A, Lingaraju G, Goldie K . Cullin-RING ubiquitin E3 ligase regulation by the COP9 signalosome. Nature. 2016; 531(7596):598-603. DOI: 10.1038/nature17416. View

Kim W, Bennett E, Huttlin E, Guo A, Li J, Possemato A . Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011; 44(2):325-40. PMC: 3200427. DOI: 10.1016/j.molcel.2011.08.025. View

Gechijian L, Buckley D, Lawlor M, Reyes J, Paulk J, Ott C . Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands. Nat Chem Biol. 2018; 14(4):405-412. PMC: 5866761. DOI: 10.1038/s41589-018-0010-y. View

Bond M, Chu L, Nalawansha D, Li K, Crews C . Targeted Degradation of Oncogenic KRAS by VHL-Recruiting PROTACs. ACS Cent Sci. 2020; 6(8):1367-1375. PMC: 7453568. DOI: 10.1021/acscentsci.0c00411. View

Zhang X, Thummuri D, Liu X, Hu W, Zhang P, Khan S . Discovery of PROTAC BCL-X degraders as potent anticancer agents with low on-target platelet toxicity. Eur J Med Chem. 2020; 192:112186. PMC: 7433031. DOI: 10.1016/j.ejmech.2020.112186. View

Hon W, Wilson M, Harlos K, Claridge T, Schofield C, Pugh C . Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature. 2002; 417(6892):975-8. DOI: 10.1038/nature00767. View

10.

Pierce N, Lee J, Liu X, Sweredoski M, Graham R, Larimore E . Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell. 2013; 153(1):206-15. PMC: 3656483. DOI: 10.1016/j.cell.2013.02.024. View

11.

Cai W, Yang H . The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions. Cell Div. 2016; 11:7. PMC: 4878042. DOI: 10.1186/s13008-016-0020-7. View

12.

Zou Z, Cao L, Zhou P, Su Y, Sun Y, Li W . Hyper-acidic protein fusion partners improve solubility and assist correct folding of recombinant proteins expressed in Escherichia coli. J Biotechnol. 2008; 135(4):333-9. DOI: 10.1016/j.jbiotec.2008.05.007. View

13.

Enchev R, Schulman B, Peter M . Protein neddylation: beyond cullin-RING ligases. Nat Rev Mol Cell Biol. 2014; 16(1):30-44. PMC: 5131867. DOI: 10.1038/nrm3919. View

14.

Pierce N, Kleiger G, Shan S, Deshaies R . Detection of sequential polyubiquitylation on a millisecond timescale. Nature. 2009; 462(7273):615-9. PMC: 2791906. DOI: 10.1038/nature08595. View

15.

Burslem G, Smith B, Lai A, Jaime-Figueroa S, McQuaid D, Bondeson D . The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. Cell Chem Biol. 2017; 25(1):67-77.e3. PMC: 5831399. DOI: 10.1016/j.chembiol.2017.09.009. View

16.

Crew A, Raina K, Dong H, Qian Y, Wang J, Vigil D . Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1. J Med Chem. 2017; 61(2):583-598. DOI: 10.1021/acs.jmedchem.7b00635. View

17.

Wu T, Yoon H, Xiong Y, Dixon-Clarke S, Nowak R, Fischer E . Targeted protein degradation as a powerful research tool in basic biology and drug target discovery. Nat Struct Mol Biol. 2020; 27(7):605-614. PMC: 7923177. DOI: 10.1038/s41594-020-0438-0. View

18.

Farnaby W, Koegl M, McConnell D, Ciulli A . Transforming targeted cancer therapy with PROTACs: A forward-looking perspective. Curr Opin Pharmacol. 2021; 57:175-183. DOI: 10.1016/j.coph.2021.02.009. View

19.

Maniaci C, Hughes S, Testa A, Chen W, Lamont D, Rocha S . Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation. Nat Commun. 2017; 8(1):830. PMC: 5635026. DOI: 10.1038/s41467-017-00954-1. View

20.

Cardote T, Gadd M, Ciulli A . Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex. Structure. 2017; 25(6):901-911.e3. PMC: 5462531. DOI: 10.1016/j.str.2017.04.009. View